GlassScriptPhysician profile
Sarah D Woll
NPI 1063164572
$438.65
in general payments reported to CMS, 2019-2025
9 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $200 · 2024: $75.79 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $140.04 | 2023-2024 | Jornay Pm |
| Seqirus USA INC | $103.40 | 2023-2025 | Flucelvax, Fluad |
| Sanofi-Aventis U.S. LLC | $61.82 | 2025 | |
| Cranial Technologies, INC | $42.31 | 2024-2025 | Doc Band |
| Ultragenyx Pharmaceutical INC. | $22.94 | 2023 | Crysvita |
| Collegium Pharmaceutical, INC. | $21.64 | 2025 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $17.24 | 2025 | Zoryve |
| Photonicare INC | $15.00 | 2025 | Otosight Middle Ear Scope |
| Pfizer INC. | $14.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Woll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.